JULIE CARR: Open Payments
NPI 1386980795 · SALE CREEK, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$937 in 44 payments from 16 companies in 2025. Trend: 2023 $926 · 2024 $882 · 2025 $937
Food & beverage: $937
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $231 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $90 |
| Otsuka America Pharmaceutical, Inc. | 4 | $87 |
| Radius Health, Inc. | 3 | $78 |
| Novo Nordisk Inc | 4 | $70 |
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Alkermes, Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $38 |
Products named: QULIPTA, Kerendia, REXULTI, Tymlos, VRAYLAR, JARDIANCE, CAPLYTA, LYBALVI.
Industry payments across TN — which companies pay providers there.
